Epidural injection of xylazine for perineal analgesia in horses.

The research article investigates the use of the drug xylazine, an alpha 2 agonist, for perineal analgesia in horses via epidural injection. The study concludes that this method is both safe and effective in providing pain relief without causing significant side effects such as hind limb weakness.

Objective of the Research

• The main goal of this study is to investigate the suitability and effectiveness of epidural injection of xylazine for perineal analgesia in horses.

The Rationale of the Study

• The research arises from the issue that local anesthetics, when given in the horse’s epidural space, often lead to hind limb weakness in addition to pain relief.
• Alpha 2 agonists, such as xylazine, are known to cause sensory blockade without motor effects in humans and other species. This characteristic makes it an appealing choice in veterinary anesthesia.

Methodology and Findings

• The study utilized xylazine, 0.9% NaCl, and lidocaine, which were delivered by epidural injection, to horses subjected to perineal electrical stimulation. The dosage for xylazine used was 0.17 mg/kg of body weight, diluted to a 10 ml volume with 0.9% NaCl.
• The results showed that administering xylazine induced approximately 2.5 hours of local analgesia without apparent side effects. However, at higher doses, mild hind limb ataxia was observed.
• The comparable administration of lidocaine also induced a similar duration of analgesia, but resulted in severe hind limb ataxia in all cases.

Conclusion of the Research

• The conclusion drawn from this research is that xylazine, when delivered by epidural injection, produces safe and effective perineal analgesia in horses.
• Compared to the use of lidocaine, xylazine resulted in less severe side effects, making it a more preferable choice in managing perineal pain in horses.